TABLE 3.
Percentage of serum samples per disease group showing preferential reactivity for individual species by methods I and II
Clinical manifestation | %
Reactivitya
|
|||
---|---|---|---|---|
B.b.ss | B.g. | B.a. | B.v. | |
Neuroborreliosis (n = 31) | 6 | 52 | 22 | 10 |
ACA (n = 31) | 7 | 3 | 84 | 0 |
Arthritis (n = 34) | 62 | 0 | 29 | 3 |
B.b.ss. B. burgdorferi sensu stricto; B.g., B. garinii; B.a., B. afzelii; B.v., B. valaisiana.